Isolated lung perfusion for the treatment of pulmonary metastases current mini-review of work in progress

Surgical Oncology

Volumn 12, Issue 3, 2003, Pages 187-193

  Van Putte, Bart P ^a   Hendriks, Jeroen M H ^a   Romijn, Sander ^a   Van Schil, Paul E Y ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

First pass effect; Gemcitabine; Isolated lung perfusion; Lung metastases; Pulmonary metastasectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DIGITOXIN; DOXORUBICIN; FLOXURIDINE; GEMCITABINE; MELPHALAN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

CANCER SURVIVAL; CLIP; DOG; HUMAN; ISOLATED LUNG; LUNG INJURY; LUNG METASTASIS; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; TOXICITY; TREATMENT OUTCOME;

EID: 0041760973     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(03)00039-2     Document Type: Review

References (43)

1. Jemel A., Thomas A., Murray T., Thun M. Cancer statistics. CA Cancer Journal for Clinicians. 52:2002;23-47.
2. Koehne C-.H., Cunningham D., Costanzo Di., Glimelius B., Blijham G., Aranda E., Scheithauer W., Rougier P., Palmer M., Wils J., Baron B., Pignatti F., Schoeffski P., Micheel S., Hecker H. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer. results of a multivariate analysis of 3825 patients Annals of Oncology. 10:2002;308-317.
3. Pastorino U., Buyse M., Friedel G., Ginsberg R.J., Girard P., Goldstraw P., Johnston M., McCormack P., Pass H., Putnam J.B. Long-term results of lung metastasectomy. prognostic analysis based on 5206 cases Journal of Thoracic and Cardiovascular Surgery. 113:1997;37-49.
4. Hendriks J., Van Schil P. Isolated lung perfusion for the treatment of pulmonary metastases. Surgical Oncology. 7:1999;59-63.
5. Creech O., Krementz E.T., Ryan R.F., Winblad J.N. Chemotherapy of cancer. regional perfusion utilizing an extracorporeal circuit Annals of Surgery. 148:1959;616-632.
6. Pierpont H., Blades B. Lung perfusion with chemotherapeutic agents. Journal of Thoracic and Cardiovascular Surgery. 39:1960;159-165.
7. Jacobs J.K., Flexner J.M., Scott H.W. Jr. Selective isolated lung perfusion of the right lung. Journal of Thoracic and Cardiovascular Surgery. 42:1961;546-552.
8. Johnston M.R., Minchin R., Shull J.H.et al. Isolated lung perfusion with adriamycin. A preclinical study. Cancer. 52:1983;404-409.
9. Johnston M.R., Christensen C.W., Minchin R.F.et al. Isolated total lung perfusion as a means to deliver organ-specific chemotherapy. long-term studies in animals Surgery. 1985;35-44.
10. Johnston M.R., Minchin R., Dawson C.A. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. Journal of Thoracic and Cardiovascular Surgery. 110:1995;368-373.
11. Mochizuki A., Kurihara Y., Yokote K., Nakajima Y., Osada H. Discrimination of solitary pulmonary nodules based on vascular supply patterns with first-pass dynamic CT. Lung Cancer. 29(Suppl. 1):2000;242.
12. Miller B.J., Rosenbaum A.S. The vascular supply to metastatic tumors of the lung. Surgery, Gynecology and Obstetrics. 1967;1009-1012.
13. Weksler B., Schneider A., Ng B., Burt M. Isolated lung perfusion in the rat. an experimental model Journal of Applied Physiology. 74:1993;2739-2739.
14. Wang H.Y., Port J.L., Hochwald S.N., Burt M.E. Revised technique of isolated lung perfusion in the rat. Annals of Thoracic Surgery. 60:1995;211-212.
15. Hendriks J.M.H., Van Schil P.E.Y., Eyskens E.J.M. Modified technique of isolated left lung perfusion in the rat. European Surgical Research. 31:1999;93-96.
16. Nawata S., Abolhoda A., Ross H.M., Brooks A., Burt M.E. Sequential bilateral isolated lung perfusion in the rat. an experimental model Annals of Thoracic Surgery. 63:1997;796-799.
17. Baciewicz F.A., Arredondo M., Chaudhuri B., Crist K.A., Basilius D., Bandyopadhyah S., Thomford N.R., Chaudhuri P.K. Pharmacokinetics and toxicity of isolated lung perfusion with doxorubicin. Journal of Surgical Research. 50:1991;124-128.
18. Weksler B., Lenert J., Ng B., Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. Journal of Thoracic and Cardiovascular Surgery. 107:1994;50-54.
19. Abolhoda A., Brooks A., Nawata S., Kaneda Y., Cheng H., Burt M.E. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Annals of Thoracic Surgery. 64:1997;181-184.
20. Weksler B., Blumberg D., Lenert J.T., Ng B., Fong Y., Burt M.E. Isolated single-lung perfusion with TNF-α in a rat sarcoma lung metastases model. Annals of Thoracic Surgery. 58:1994;328-332.
21. Vassalli P. The pathophysiology of tumor necrosis factor. Annual Review of Immunology. 10:1992;411-452.
22. Hendriks J.M.H., Van Schil P.E.Y., De Boeck G., Van Oosterom A., Van Marck E., Eyskens E.J.M. Isolated lung perfusion with melphalan and tumor necrosis factor for pulmonary adenocarcinoma. Annals of Thoracic Surgery. 66:1998;1719-1725.
23. Hendriks J.M.H., Van Schil P.E.Y., Van Oosterom A.A.T., Kuppen P.J.K., Van Marck E., Eyskens E. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma. European Surgical Research. 31:1999;267-271.
24. Nawata S., Abecasis N., Ross H.M., Abolhoda A., Cheng H., Sachar K.S., Burt M.E. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. Journal of Thoracic and Cardiovascular Surgery. 112:1996;1542-1548.
25. Pogrebniak H.W., Witt C., Terrill R., Kranda K., Travis W.D., Rosenberg S.A., Pass H.I. Isolated lung perfusion with tumor necrosis factor. a swine model in preparation of human trials Annals of Thoracic Surgery. 57:1994;1477-1483.
26. Ng B., Lenert J.T., Weksler B., Port J.L., Ellis J.L., Burt M.E. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Annals of Thoracic Surgery. 59:1995;205-208.
27. Schrump D.S., Zhai S., Nguyen D.M., Weiser T.S., Fisher B.A., Terrill R.E., Flynn B.M., Duray P.H., Figg W.D. Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques. Journal of Thoracic and Cardiovascular Surgery. 123:2002;686-694.
28. Tanaka T., Kaneda Y., Li T., Matsuoka T., Zempo N., Esato K. Digitonin enhances the antitumor effect of cisplatin during isolated lung perfusion. Annals of Thoracic Surgery. 72:2001;1173-1178.
29. Krueger T., kümmerle A., Vallet C., Pan Y., Decosterd L., Ris H.B. Antegrade and retrograde isolated lung perfusion (ILP) with doxorubicin in the rat. comparison of pharmacokinetics and toxicity European Respiratory Journal. 20(Suppl. 38):2002;179.
30. Rickaby D.A., Fehring J.F., Johnston M.R., Dawson C.A. Tolerance of the isolated lung to hyperthermia. Journal of Thoracic and Cardiovascular Surgery. 101:1991;732-739.
31. Van Putte BP, Hendriks JMH, Romijn S, Pauwels B, Friedel G, Guetens G, De Bruijn E, Van Schil PEY. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. Journal of Surgical Research 2003;109:118-22.
32. Van Putte BP, Hendriks JMH, Vermeulen PB, Romijn S, Van Marck E, Van Schil PEY. Isolated lung perfusion with gemcitabine prolongs survival in a rat model of metastatic pulmonary adenocarcinoma, submitted for publication.
33. Romijn S., Hendriks J.M.H., Van Putte B.P., Guetens G., Van Schil P.E.Y. Variations in flow duration and concentration do not change the final lung concentrations of melphalan after isolated lung perfusion in rats. European Surgical Research. 35:2003;50-53.
34. Van Putte BP, Hendriks JMH, Romijn S, Pauwels B, Guetens G, De Bruijn E, Van Schil PEY. Pharmacokinetics after pulmonary perfusion with gemcitabine. Annals of Thoracic Surgery, in press.
35. Van Putte B.P., Hendriks J.M.H., Romijn S., Guetens G., De Boeck, De Bruijn E, Van Schil P.E.Y. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Annals of Thoracic Surgery. 74:2002;893-898.
36. Schneider P., Kampfer S., Loddenkemper C., Foitzik T., Buhr H.J. Chemoembolization of the lung improves tumor control in a rat model. Clinical Cancer Research. 8:2002;2463-2468.
37. Linder A., Friedel G., Fritz P., Kivisto K.T., McClellan M., Toomes H. The ex-vivo isolated, perfused human lung model. description and potential applications Thoracic and Cardiovascular Surgeon. 44:1996;140-146.
38. Murdter T.E., Sperker B., Kivisto K.T., McClellan M., Fritz P., Friedel G., Linder A., Bosslet K., Toomes H., Dierkesmann R., Kroemer H.K. Enhanced uptake of doxorubicine into bronchial carcinoma. beta-glucoronidase mediates release of doxorubicine from a glucuronide prodrug (HMR 1826) at the tumour site Cancer Research. 57:1997;2440-2445.
39. Murdter T.E., Linder A., Friedel G., McClellan M., Bohnenstengel F., Sperker B., Kroemer H.K., Toomes H., Freitag L., Fritz P. Pharmacokinetics of cyclophosphamide, adriamycine and adriamycine prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP). Pneumologie. 54:2000;494-498.
40. Pass H.I., Mew D.J.Y., Kranda K.C., Tmeck B.T., Donington J.S., Rosenberg S.A. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Annals of Thoracic Surgery. 61:1996;1609-1617.
41. Burt M.E., Liu D., Abolhoda A., Ross H.M., Kaneda Y., Jara E., Casper E.S., Ginsberg R.J., Brennan M.F. Isolated lung perfusion for patients with unresectable metastases from sarcoma. a phase I trial Annals of Thoracic Surgery. 69:2000;1542-1549.
42. Ratto G.B., Toma S., Civalleri D., Passerone G.C., Esposito M., Zaccheo D., Canepa M., Romano P., Palumbo R., De Cian F., Scarano F., Vannozzi M., Spessa E., Fantino G. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. Journal of Thoracic and Cardiovascular Surgery. 112:1996;614-622.
43. Putnam J.B. New and evolving treatment methods for pulmonary metastases. Seminars in Thoracic and Cardiovascular Surgery. 14:2002;49-56.